This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Eli Lilly and Company. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Deidre Michelle Johns - Innovating AKT Inhibitors at Eli Lilly and Company
Introduction: Deidre Michelle Johns is a talented inventor based in Indianapolis, IN, with a passion for developing pharmaceutical solutions. With a keen focus on AKT inhibitors, Deidre is making waves in the field of medicine and patents.
Latest Patents: Deidre Michelle Johns holds one patent for AKT inhibitors, which are represented by a unique formula (Formula I). This patent not only covers the compounds themselves but also extends to pharmaceutical compositions, methods of use, and potential applications in the healthcare industry.
Career Highlights: Working at Eli Lilly and Company, Deidre Michelle Johns demonstrates his expertise in research and development. His dedication to exploring AKT inhibitors showcases a commitment to advancing medical treatments and improving patient outcomes.
Collaborations: Deidre Michelle Johns collaborates closely with esteemed colleagues such as Douglas Wade Beight and Timothy Paul Burkholder. Together, they form a dynamic team at Eli Lilly and Company, driving innovation and pushing the boundaries of pharmaceutical science.
Conclusion: Deidre Michelle Johns is a pioneering inventor at Eli Lilly and Company, spearheading efforts to create novel AKT inhibitors with far-reaching implications for healthcare. His patent stands as a testament to his inventive spirit and contributions to the field of medicine.